Free Republic
Browse · Search
News/Activism
Topics · Post Article

To: neverdem
The Boehringer Ingelheim drug Micardis, or telmisartan, was as effective in preventing serious heart problems in high-risk patients as certain older drugs

Oddly enough, the study was sponsored by none other than Boehringer Ingelheim Pharmaceuticals.

2 posted on 04/01/2008 12:40:17 AM PDT by NautiNurse (Plants are people too)
[ Post Reply | Private Reply | To 1 | View Replies ]


To: NautiNurse
Oddly enough, the study was sponsored by none other than Boehringer Ingelheim Pharmaceuticals.

Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events

(ClinicalTrials.gov number, NCT00153101 [ClinicalTrials.gov])

"Supported by a grant from Boehringer Ingelheim, the Heart and Stroke Foundation of Ontario, and a Senior Scientist Award from the Canadian Institutes of Health Research (to Dr. Yusuf)."

Who do you want to pay for it?

3 posted on 04/01/2008 4:09:20 AM PDT by neverdem (I'm praying for a Divine Intervention.)
[ Post Reply | Private Reply | To 2 | View Replies ]

To: NautiNurse

hi
you will find lot of information in this site


abilash s

get more info from Universal Technical Institute on programs of your choice

http://snipurl.com/-uti


5 posted on 04/08/2008 4:36:16 AM PDT by sabilash81
[ Post Reply | Private Reply | To 2 | View Replies ]

Free Republic
Browse · Search
News/Activism
Topics · Post Article


FreeRepublic, LLC, PO BOX 9771, FRESNO, CA 93794
FreeRepublic.com is powered by software copyright 2000-2008 John Robinson